top of page
Group 371.png


Oops- this event doesn't have a website associated with it.


But don't worry, the Aguettant team will still be there to showcase Dzuveo®.


Fill in the form below for more information on this event, or anything else.


Contact us for more information on this event

Simply fill in the form, and an Aguettant team member will get in touch shortly.

Thanks for submitting!

3 steps to Dzuveo® 
sublingual sufentanil tablets


Watch our 'How to' Dzuveo® video to see just how easy it is to use - making it ideal for many different clinical settings including emergency and trauma, post-operative pain, and painful procedures.


Sign up for our emails to receive the latest news about Dzuveo®, including updates on new clinical data, support tools and product availability.


Request an appointment with an Aguettant Key Account Manager to discuss how Dzuveo® can help you and your patients better control pain.

Safety information

Dzuveo is to be administered by a healthcare professional in a medically monitored setting only. A medically monitored setting must have equipment and personnel trained to detect and manage hypoventilation, and availability of supplemental oxygen and opioid antagonists, such as naloxone. Dzuveo should only be prescribed and administered by healthcare professionals who are experienced in the management of opioid therapy; particularly opioid adverse reactions, such as respiratory depression

bottom of page